Clinical Trials Browser

Phase 2 × Bronchial Neoplasms × osimertinib × Clear all

NCT04974879 2023-03-29

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Phase 2 Unknown

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung